Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul;22(7):1451-64.
doi: 10.1007/s00330-012-2446-x. Epub 2012 May 7.

Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging

M O Leach  1 , B Morgan, P S Tofts, D L Buckley, W Huang, M A Horsfield, T L Chenevert, D J Collins, A Jackson, D Lomas, B Whitcher, L Clarke, R Plummer, I Judson, R Jones, R Alonzi, T Brunner, D M Koh, P Murphy, J C Waterton, G Parker, M J Graves, T W J Scheenen, T W Redpath, M Orton, G Karczmar, H Huisman, J Barentsz, A Padhani; Experimental Cancer Medicine Centres Imaging Network Steering Committee
Collaborators, Affiliations

Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging

M O Leach et al. Eur Radiol. 2012 Jul.

Abstract

Many therapeutic approaches to cancer affect the tumour vasculature, either indirectly or as a direct target. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has become an important means of investigating this action, both pre-clinically and in early stage clinical trials. For such trials, it is essential that the measurement process (i.e. image acquisition and analysis) can be performed effectively and with consistency among contributing centres. As the technique continues to develop in order to provide potential improvements in sensitivity and physiological relevance, there is considerable scope for between-centre variation in techniques. A workshop was convened by the Imaging Committee of the Experimental Cancer Medicine Centres (ECMC) to review the current status of DCE-MRI and to provide recommendations on how the technique can best be used for early stage trials. This review and the consequent recommendations are summarised here. Key Points • Tumour vascular function is key to tumour development and treatment • Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can assess tumour vascular function • Thus DCE-MRI with pharmacokinetic models can assess novel treatments • Many recent developments are advancing the accuracy of and information from DCE-MRI • Establishing common methodology across multiple centres is challenging and requires accepted guidelines.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Phys Med Biol. 2009 Apr 7;54(7):2197-215 - PubMed
    1. Magn Reson Med. 2009 Aug;62(2):488-99 - PubMed
    1. Biorheology. 1980;17(1-2):183-9 - PubMed
    1. Magn Reson Imaging. 1993;11(6):817-33 - PubMed
    1. Br J Radiol. 2003;76 Spec No 1:S87-91 - PubMed

Publication types

LinkOut - more resources